UroGen Pharma Ltd.
URGN
$19.48
-$0.30-1.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 156.95M | 195.89M | 236.69M | 249.58M | 241.08M |
| Total Receivables | 19.65M | 19.64M | 20.30M | 22.80M | 17.42M |
| Inventory | 7.13M | 7.59M | 9.23M | 7.59M | 7.44M |
| Prepaid Expenses | 12.06M | 12.98M | 8.85M | 14.05M | 12.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.08M | 1.08M | 1.08M | 1.07M | 825.00K |
| Total Current Assets | 196.87M | 237.18M | 276.14M | 295.10M | 278.97M |
|
|
|||||
| Total Current Assets | 196.87M | 237.18M | 276.14M | 295.10M | 278.97M |
| Net Property, Plant & Equipment | 6.24M | 5.38M | 3.79M | 1.66M | 1.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 978.00K | 547.00K | 765.00K | 545.00K | 848.00K |
| Total Assets | 208.72M | 247.62M | 285.71M | 301.94M | 281.85M |
|
|
|||||
| Total Accounts Payable | 13.56M | 14.57M | 10.93M | 5.56M | 8.32M |
| Total Accrued Expenses | 29.04M | 22.72M | 27.07M | 23.16M | 22.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.55M | 1.41M | 1.53M | 825.00K | 796.00K |
| Total Finance Division Other Current Liabilities | 3.39M | 3.30M | 6.42M | 3.25M | 2.82M |
| Total Other Current Liabilities | 3.39M | 3.30M | 6.42M | 3.25M | 2.82M |
| Total Current Liabilities | 47.55M | 42.00M | 45.95M | 32.79M | 34.22M |
|
|
|||||
| Total Current Liabilities | 47.55M | 42.00M | 45.95M | 32.79M | 34.22M |
| Long-Term Debt | 122.51M | 122.11M | 121.73M | 121.71M | 97.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.41M | 2.84M | 1.65M | 212.00K | 425.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 128.62M | 127.13M | 125.18M | 121.72M | 119.07M |
| Total Liabilities | 302.09M | 294.08M | 294.51M | 276.43M | 251.54M |
|
|
|||||
| Common Stock & APIC | 806.62M | 803.59M | 797.36M | 793.99M | 775.38M |
| Retained Earnings | -900.01M | -850.07M | -806.22M | -768.71M | -745.04M |
| Treasury Stock & Other | 6.00K | 14.00K | 56.00K | 236.00K | -31.00K |
| Total Common Equity | -93.38M | -46.46M | -8.80M | 25.52M | 30.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.38M | -46.46M | -8.80M | 25.52M | 30.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -93.38M | -46.46M | -8.80M | 25.52M | 30.31M |
|
|
|||||